Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?. // Journal of Traditional and Complementary Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2213294526002152?dgcid=rss_sd_all
Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?. Journal of Traditional and Complementary Medicine. https://www.sciencedirect.com/science/article/pii/S2213294526002152?dgcid=rss_sd_all
“Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?.” Journal of Traditional and Complementary Medicine.
@article{article1931,
title = {Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?},
journal = {Journal of Traditional and Complementary Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2213294526002152?dgcid=rss_sd_all}
}
Publication date: September 2026 Source: Informatics and Health, Volume 3, Issue 2 Author(s): Carlo Andrea Cossu, Mattia Trapani, Jan E. Crafford, Louis O. van Schalkwyk, Raksha V. Bhoora, Lin-Mari De Klerk, Giorgio P. Biondetti,...